CARUBBI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.117
AS - Asia 4.429
EU - Europa 4.248
SA - Sud America 615
AF - Africa 81
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.007
GB - Regno Unito 1.564
CN - Cina 1.452
SG - Singapore 1.434
IT - Italia 844
HK - Hong Kong 731
BR - Brasile 495
DE - Germania 446
SE - Svezia 391
RU - Federazione Russa 210
TR - Turchia 202
UA - Ucraina 185
VN - Vietnam 185
FI - Finlandia 147
KR - Corea 129
FR - Francia 123
BG - Bulgaria 82
ID - Indonesia 73
CA - Canada 58
NL - Olanda 55
IN - India 54
AR - Argentina 52
MX - Messico 32
IE - Irlanda 27
ZA - Sudafrica 27
JP - Giappone 25
RO - Romania 23
EG - Egitto 22
PL - Polonia 22
BD - Bangladesh 20
BE - Belgio 20
EC - Ecuador 20
AT - Austria 19
LT - Lituania 18
ES - Italia 16
IQ - Iraq 15
MY - Malesia 15
AU - Australia 13
IR - Iran 13
VE - Venezuela 13
DK - Danimarca 12
CZ - Repubblica Ceca 10
SA - Arabia Saudita 10
CO - Colombia 9
QA - Qatar 9
CL - Cile 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
IL - Israele 7
JO - Giordania 7
MA - Marocco 7
PK - Pakistan 7
TN - Tunisia 7
GR - Grecia 6
MK - Macedonia 6
PE - Perù 6
PY - Paraguay 6
CH - Svizzera 5
PA - Panama 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
HN - Honduras 4
RS - Serbia 4
SI - Slovenia 4
UY - Uruguay 4
ET - Etiopia 3
KE - Kenya 3
KZ - Kazakistan 3
NP - Nepal 3
PT - Portogallo 3
AL - Albania 2
BF - Burkina Faso 2
BO - Bolivia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
GE - Georgia 2
LB - Libano 2
NG - Nigeria 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
CV - Capo Verde 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 18.502
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.082
Southend 1.062
Singapore 973
Fairfield 889
Ashburn 746
Hong Kong 724
Chandler 659
Woodbridge 641
Hefei 599
Houston 443
Jacksonville 390
Seattle 344
Wilmington 332
Cambridge 321
Dearborn 297
Ann Arbor 255
London 248
Nyköping 243
Beijing 212
Los Angeles 142
Modena 129
Seoul 128
Izmir 112
San Diego 103
New York 102
Princeton 92
Bremen 83
Sofia 81
Chicago 78
Eugene 70
Helsinki 65
Moscow 64
Grafing 61
Ho Chi Minh City 58
Jakarta 58
Des Moines 57
Buffalo 55
Munich 52
The Dalles 50
Milan 48
Shanghai 46
Hanoi 43
São Paulo 43
Council Bluffs 41
Falls Church 41
Dallas 38
Rome 35
Reggio Emilia 31
Columbus 30
Bologna 29
Salt Lake City 29
Kent 27
Nuremberg 27
San Jose 27
Parma 25
Boardman 23
Dublin 23
Phoenix 23
Frankfurt am Main 22
Brussels 19
Elk Grove Village 19
Guangzhou 19
Nanjing 19
Redwood City 19
Amsterdam 18
Johannesburg 17
Montreal 17
Tokyo 17
Brooklyn 16
Warsaw 16
Atlanta 15
Denver 15
Timisoara 15
Norwalk 14
Poplar 14
Tampa 14
Fremont 13
Orem 13
Ottawa 13
Redondo Beach 13
Turku 13
Verona 13
Belo Horizonte 12
Haiphong 12
Kunming 12
Mumbai 12
Stockholm 12
Mexico City 11
Rio de Janeiro 11
Toronto 11
Abbiategrasso 10
Boston 10
Brøndby 10
Manchester 10
Naples 10
Porto Alegre 10
San Francisco 10
Chennai 9
São José dos Campos 9
Vienna 9
Totale 13.302
Salva come PNG Salva come JPEG
Nome #
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 474
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 389
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 347
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 328
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 322
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 310
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 305
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 303
Growth of human herpesvirus 6 in HepG2 cells 295
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 293
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 269
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 264
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 263
Management of bone disease in Gaucher disease type 1: clinical practice 261
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 256
Cholesterol esterase activity of human intestinal mucosa 255
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 253
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 253
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 252
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 249
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 248
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 247
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 245
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 244
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 243
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 238
Anatomia e fisiologia delle vie biliari 236
Fabry disease: raising awareness of the disease among physicians 224
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 221
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 221
Review article: effect of bile salt pool composition on hepatic and biliary functions 220
Bile acid structure and regulation of biliary protein secretion and composition in man 218
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 217
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 216
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 216
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 214
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 213
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 210
Global multi-stakeholder endorsement of the MAFLD definition 209
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 209
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 209
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 203
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 203
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 201
Minimal disease activity in Gaucher disease: criteria for definition 196
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 192
Bile acid and hepatocyte death 191
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 189
Cholesterol Esterase Activity of human intestinal mucosa 188
Cholesterol esterase activity of human intestinal mucosa 187
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 183
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 178
Nonalcoholic fatty liver disease induced by leuprorelin acetate 177
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 172
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 162
Patogenesi della colelitiasi 161
Regulation of cholesterol absorption in humans 159
Gaucher Disease in Bone: From Pathophysiology to Practice 157
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 156
Hyperferritinemia and diagnosis of type 1 Gaucher disease 156
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 155
Prevalence rates of gallstone disease in Italy: the Chianciano population study 154
Nuove prospettive terapeutiche con acidi biliari. 151
Inquadramento delle sindromi colestatiche. 147
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 146
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 144
Cholesterol esterase activity in the small bowel of humans 143
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 142
Regulation of bile acid synthesis in humans 142
Nutrition in adult patients with selected lysosomal storage diseases 142
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 139
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 136
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 136
Malattie delle vie biliari 133
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 132
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 131
LA SECREZIONE LIPIDICA BILIARE 130
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 127
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 125
Liver metastases from carcinoid tumor: Imaging patterns 122
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 118
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 117
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 112
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 111
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 107
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 106
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 102
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 99
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 98
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 93
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 93
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 91
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 80
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 78
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 73
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 72
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease 71
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 68
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 68
Towards needed improvements in inherited metabolic medicine in adulthood: The SIMMESN adult metabolic working group and MetabERN Joint Position Statement 45
Totale 18.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.819
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.259 0 0 0 0 0 84 352 317 93 206 106 101
2021/20221.764 89 202 125 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/20254.140 134 54 61 279 750 581 343 211 353 205 543 626
2025/20263.674 484 339 643 781 1.062 365 0 0 0 0 0 0
Totale 18.649